Towards Personalized Sampling in Clear Cell Renal Cell Carcinomas.

Area of Science:

• Oncology
• Cancer Research
• Genomics

Background:

• Intratumor heterogeneity (ITH) is a significant challenge in cancer treatment, particularly in clear cell renal cell carcinoma (CCRCC).
• ITH contributes to therapeutic failures, underscoring the need for improved detection methods in precision oncology.
• Current sampling methods often fail to capture the full extent of ITH.

Purpose of the Study:

• To introduce and evaluate a novel sampling strategy, personalized multisite tumor sampling (pMSTS), for enhanced detection of ITH in CCRCC.
• To address the limitations of traditional sampling protocols by incorporating knowledge of ITH regionalization patterns.

Main Methods:

• Development of personalized multisite tumor sampling (pMSTS) protocol.
• Focusing sampling efforts on the tumor periphery, identified as a region with maximal ITH.
• Comparison of pMSTS with traditional sampling methods for ITH assessment in CCRCC.

Main Results:

• The tumor periphery exhibits the highest levels of intratumor heterogeneity.
• pMSTS strategy enhances the detection of ITH by prioritizing sampling of the tumor periphery.
• This targeted approach offers a more accurate representation of CCRCC's evolutionary landscape.

Conclusions:

• Personalized multisite tumor sampling (pMSTS) represents a significant advancement in addressing ITH in CCRCC.
• This refined sampling strategy is crucial for improving diagnostic accuracy and guiding effective precision oncology treatments.
• Further implementation of pMSTS is recommended for better management of CCRCC patients.